Electronic Intervention to Chronic Opioid Therapy

An Electronic Chart Intervention to Improve Safety for Patients on Chronic Opioid Therapy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04198961

Enrollment

Registered

2019-12-13

Start date

2020-06-17

Completion date

2021-06-17

Last updated

2021-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Opioid Therapy

Brief summary

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

Interventions

OTHERopioid prescribing

Individualized taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients prescribed long-term opioid therapy of doses greater than 90 morphine equivalent daily dose (MEDD)

Exclusion criteria

* Patients prescribed short-term opioid medications for acute pain (less than a 90-day supply over the past 120 days), sublingual buprenorphine, methadone maintenance for opioid use disorder or with oncology or palliative care diagnoses will be excluded.

Design outcomes

Primary

Measure	Time frame	Description
Change in the number of patients who receives naloxone prescription	baseline, 1, 3- and 6-months and 12 months	Change in the number of patients who receives naloxone prescription
change of number of documentation about safety discussions	baseline, 1, 3- and 6-months and 12 months	change of number of documentation about safety discussions
change of number of order for urine toxicology screening	baseline, 1, 3- and 6-months and 12 months	change of number of order for urine toxicology screening
change of number of documentation of prescription drug monitoring program (CURES) results	baseline, 1, 3- and 6-months and 12 months	change of number of documentation of prescription drug monitoring program (CURES) results
change of number of signed opioid informed consent forms	baseline, 1, 3- and 6-months and 12 months	change of number of signed opioid informed consent forms

Secondary

Measure	Time frame	Description
Change in number of patients on long-term high risk doses of opioid pain medications	baseline, 1, 3- and 6-months and 12 months	decreases in daily dose of opioids and number of patients on opioids ≥ 90mg MEDD

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026